Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02296892 · ClinicalTrials.gov registry record · Phase 3
A Phase III Study of Remimazolam in Patients Undergoing Bronchoscopy
A Phase 3 study of Bronchoscopy, sponsored by Paion UK.
- Completed
- Registry status
- Phase 3
- Development phase
- 446
- Enrollment target
- 14
- Study locations
NCT02296892 is a Phase 3 study of Bronchoscopy that has completed, run by Paion UK. The registered enrollment target is 446 participants. The trial reports 14 study locations across 8 states.
The verdict
NCT02296892, a Phase 3 study of Bronchoscopy, has completed, sponsored by Paion UK.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 446 participants
- Enrollment target
- 14
- Study locations
Study Summary
A prospective, double-blind, randomized, placebo and active controlled, multi-center, parallel group study comparing remimazolam to placebo, with an additional open label arm for midazolam, in patients undergoing a bronchoscopy.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Midazolam
- DRUG Remimazolam
Study Locations (14)
North Carolina
- Unc Division of Pulmonary and Critical Care - Chapel Hill
- Duke University - Durham
- Pinehurst Medical Clinic - Pinehurst
- Wake Forest Baptist Health - Winston-Salem
Florida
- Pab Clinical Research - Brandon
- Sun City Office - Sun City Center
South Carolina
- Medical University of South Carolina - Charleston
- S. Carolina Pharmaceutical Research - Spartanburg
Virginia
- Pulmonary Associates of Richmond - Richmond
- Virginia Commonwealth University - Richmond
Indiana
- Laporte County Institute For Clinical Research - Michigan City
Maryland
- The Johns Hopkins Center for Interventional and Pulmonary Care - Baltimore
Missouri
- Washington University School of Medicine/Barnes-Jewish Hospital - St Louis
Washington
- Multicare Institute For Research & Innovation - Tacoma
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 446 participants |
| Start Date | 2015-04 |
| Est. Completion | 2017-03-13 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02296892
The ClinicalTrials.gov registry entry for NCT02296892 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 446 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Paion UK, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Bronchoscopy appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT02296892 reports 14 study locations spanning 8 distinct geographic areas - top geographies include North Carolina, Florida, South Carolina.
Frequently Asked Questions
What is clinical trial NCT02296892 about?
NCT02296892 is a clinical study titled "A Phase III Study of Remimazolam in Patients Undergoing Bronchoscopy". A prospective, double-blind, randomized, placebo and active controlled, multi-center, parallel group study comparing remimazolam to placebo, with an additional open label arm for midazolam, in patients undergoing a bronchoscopy.
What is the current status of trial NCT02296892?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 446 participants. The study started on 2015-04. Estimated completion is 2017-03-13.
What conditions does trial NCT02296892 study?
This clinical trial studies the following conditions: Bronchoscopy.
What interventions are being tested in trial NCT02296892?
The interventions under investigation include: Placebo (DRUG), Midazolam (DRUG), Remimazolam (DRUG).
Who is sponsoring clinical trial NCT02296892?
This trial is sponsored by Paion UK, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02296892 being conducted?
This trial has 14 study locations across Florida, Indiana, Maryland, Missouri, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bronchoscopy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.